Skip to main content
Log in

What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease?

  • Current Opinion
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) is a very common lung disease most often related to a history of smoking. It becomes more prevalent with increasing age but remains under-diagnosed and under-treated in the elderly population. The Global Initiative for Obstructive Lung Disease (GOLD) programme has been instrumental in providing standard diagnostic criteria as well as recommendations for prevention and management of COPD. GOLD recommendations define COPD as a post-bronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) of <70%, with the severity based on the value of FEV1. This recommendation is different from that of many previous reports that have recommended diagnosing obstruction using the statistically derived lower limit of normal (LLN), which varies for each person according to age, height, ethnicity and gender. While the use of a 70% ratio may be simpler, it may result in under-diagnosis of airflow obstruction in younger people and over-diagnosis in the elderly. This is particularly important as the elderly may be most sensitive to many of the adverse effects of medications used in the treatment of COPD, including corticosteroids and anticholinergic bronchodilators.

Most of the studies comparing the LLN and a fixed ratio of 70% have not been performed with post-bronchodilator testing as recommended by GOLD. Generation of post-bronchodilator reference sets and studies comparing the LLN with the post-bronchodilator FEV1/FVC ratio of <70% will help resolve this issue. One recent study examined patients admitted to hospitals who had an FEV1/FVC ratio of <70% but above the LLN, and found they were at increased risk of death and COPD complications. This would support the use of GOLD criteria. Further studies examining this population are needed.

In addition to the uncertainties about what diagnostic criteria should be utilized for diagnosis of airflow obstruction, different organizations make different recommendations on screening spirometry. A conservative recommendation is to perform spirometry in symptomatic individuals. It is important to remember that while COPD is under-diagnosed in the elderly, this group is also at a higher risk of being falsely classified as having airflow obstruction using the 70% ratio recommended by GOLD. This can result in unnecessary use of medications and increased risk of adverse effects to which the elderly are more prone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Piquette C, Rennard S, Snider G. Chronic bronchitis and emphysema. In: Murray J, Nadel J, editors. Textbook of respiratory medicine. Philadelphia (PA): W.B. Saunders Co., 2000: 1187–245

    Google Scholar 

  2. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 Apr; 163(5): 1256–76

    PubMed  CAS  Google Scholar 

  3. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007 [online]. Available from URL: http://www.goldcopd.org [Accessed 2008 Mar]

  4. Celli BR, MacNee W, Committee Members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6): 932–46

    Article  PubMed  CAS  Google Scholar 

  5. Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003 May; 123(5): 1684–92

    Article  PubMed  CAS  Google Scholar 

  6. Nacul LC, Soljak M, Meade T. Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England. Popul Health Metr 2007; 5: 8

    Article  PubMed  Google Scholar 

  7. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002 Aug 2; 51(6): 1–16

    Google Scholar 

  8. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005 Oct; 128(4): 2005–11

    Article  PubMed  Google Scholar 

  9. National Heart Lung, and Blood Institute. 2007 NHLBI morbidity and mortality chart book. Bethesda (MA): National Institutes of Health, 2007

    Google Scholar 

  10. Waterer GW, Wan JY, Kritchevsky SB, et al. Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 2001 Aug; 49(8): 1032–8

    Article  PubMed  CAS  Google Scholar 

  11. Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001 Aug 1; 164(3): 372–7

    PubMed  CAS  Google Scholar 

  12. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care 2000 May; 45(5): 513–30

    PubMed  CAS  Google Scholar 

  13. Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966 Sep; 21(5): 445–9

    Article  PubMed  CAS  Google Scholar 

  14. Sobol BJ, Sobol PG. Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979 Feb; 34(1): 1–3

    Article  PubMed  CAS  Google Scholar 

  15. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988 Apr; 43(4): 265–7

    Article  PubMed  CAS  Google Scholar 

  16. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999 Jan 1; 159(1): 179–87

    PubMed  CAS  Google Scholar 

  17. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD 2006 Jun; 3(2): 95–100

    Article  PubMed  Google Scholar 

  18. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986 Jun; 133(6): 1205–9

    Google Scholar 

  19. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991 Nov; 144(5): 1202–18

    Article  Google Scholar 

  20. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005 Nov; 26(5): 948–68

    Article  PubMed  CAS  Google Scholar 

  21. Janssens JP. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med 2005 Sep; 26(3): 469–84, vi–vii

    Article  PubMed  Google Scholar 

  22. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999 Jan 1; 13(1): 197–205

    Article  PubMed  CAS  Google Scholar 

  23. Zeleznik J. Normative aging of the respiratory system. Clin Geriatr Med 2003 Feb; 19(1): 1–18

    Article  PubMed  Google Scholar 

  24. Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol 1968 Dec; 25(6): 664–71

    PubMed  CAS  Google Scholar 

  25. Verbeken EK, Cauberghs M, Mertens I, et al. The senile lung: comparison with normal and emphysematous lungs: 1. Structural aspects. Chest 1992 Mar; 101(3): 793–9

    Article  PubMed  CAS  Google Scholar 

  26. Gillooly M, Lamb D. Airspace size in lungs of lifelong nonsmokers: effect of age and sex. Thorax 1993 Jan; 48(1): 39–43

    Article  PubMed  CAS  Google Scholar 

  27. Edge JR, Millard FJ, Reid L, et al. The radiographic appearances of the chest in persons of advanced age. Br J Radiol 1964 Oct; 37: 769–74

    Article  PubMed  CAS  Google Scholar 

  28. Estenne M, Yernault JC, De Troyer A. Rib cage and diaphragmabdomen compliance in humans: effects of age and posture. J Appl Physiol 1985 Dec; 59(6): 1842–8

    PubMed  CAS  Google Scholar 

  29. Enright PL, Kronmal RA, Higgins MW, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest 1994 Sep; 106(3): 827–34

    Article  PubMed  CAS  Google Scholar 

  30. Enright PL, Kronmal RA, Manolio TA, et al. Respiratory muscle strength in the elderly: correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med 1994 Feb; 149 (2 Pt 1): 430–8

    PubMed  CAS  Google Scholar 

  31. Polkey MI, Harris ML, Hughes PD, et al. The contractile properties of the elderly human diaphragm. Am J Respir Crit Care Med 1997 May; 155(5): 1560–4

    PubMed  CAS  Google Scholar 

  32. Tolep K, Higgins N, Muza S, et al. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med 1995 Aug; 152(2): 677–82

    PubMed  CAS  Google Scholar 

  33. Enright PL, Adams AB, Boyle PJR, et al. Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men. Chest 1995 Sep; 108(3): 663–9

    Article  PubMed  CAS  Google Scholar 

  34. de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly. Eur Respir J 2005 Oct 1; 26(4): 594–601

    Article  PubMed  Google Scholar 

  35. Niewoehner DE, Kleinerman J. Morphologic basis of pulmonary resistance in the human lung and effects of aging. J Appl Physiol 1974 Apr; 36(4): 412–8

    PubMed  CAS  Google Scholar 

  36. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981 Jun; 123(6): 659–64

    PubMed  CAS  Google Scholar 

  37. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983 Jun; 127(6): 725–34

    PubMed  CAS  Google Scholar 

  38. van Pelt W, Borsboom GJ, Rijcken B, et al. Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med 1994 May; 149(5): 1218–26

    PubMed  Google Scholar 

  39. Cohn JE, Donoso HD. Mechanical properties of lung in normal men over 60 years old. J Clin Invest 1963 Sep; 42: 1406–10

    Article  PubMed  CAS  Google Scholar 

  40. Sprung J, Gajic O, Warner DO. Review article: age related alterations in respiratory function — anesthetic considerations. [Article de synthese: Les modifications de fonction respiratoire liees a l’age — considerations anesthesiques]. Can J Anaesth 2006 Dec; 53(12): 1244–57

    Article  PubMed  Google Scholar 

  41. Zaugg M, Lucchinetti E. Respiratory function in the elderly. Anesthesiol Clin North America 2000 Mar; 18(1): 47–58, vi

    Article  PubMed  CAS  Google Scholar 

  42. Fowler RW, Pluck RA, Hetzel MR. Maximal expiratory flow-volume curves in Londoners aged 60 years and over. Thorax 1987 Mar; 42(3): 173–82

    Article  PubMed  CAS  Google Scholar 

  43. Babb TG, Rodarte JR. Mechanism of reduced maximal expiratory flow with aging. J Appl Physiol 2000 Aug; 89(2): 505–11

    PubMed  CAS  Google Scholar 

  44. DeLorey DS, Babb TG. Progressive mechanical ventilatory constraints with aging. Am J Respir Crit Care Med 1999 Jul; 160(1): 169–77

    PubMed  CAS  Google Scholar 

  45. Bellia V, Cibella F, Cuttitta G, et al. Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 1998 Nov; 114(5): 1336–42

    Article  PubMed  CAS  Google Scholar 

  46. Connolly MJ, Crowley JJ, Charan NB, et al. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 1995 Aug; 108(2): 401–6

    Article  PubMed  CAS  Google Scholar 

  47. Kradjan WA, Driesner NK, Abuan TH, et al. Effect of age on bronchodilator response. Chest 1992 Jun; 101(6): 1545–51

    Article  PubMed  CAS  Google Scholar 

  48. Barros MJ, Rees PJ. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Resp Med 1990 Sep; 84(5): 371–5

    Article  CAS  Google Scholar 

  49. van Schayck C, Folgering H, Harbers H, et al. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 1991; 46(5): 355–9

    Article  PubMed  Google Scholar 

  50. Schmidt CD, Dickman ML, Gardner RM, et al. Spirometric standards for healthy elderly men and women: 532 subjects, ages 55 through 94 years. Am Rev Respir Dis 1973 Oct; 108(4): 933–9

    PubMed  CAS  Google Scholar 

  51. Milne JS, Williamson J. Respiratory function tests in older people. Clin Sci 1972 Mar; 42(3): 371–81

    PubMed  CAS  Google Scholar 

  52. Enright PL, Kronmal RA, Higgins M, et al. Spirometry reference values for women and men 65 to 85 years of age: Cardiovascular Health Study. Am Rev Respir Dis 1993 Jan; 147(1): 125–33

    Article  PubMed  CAS  Google Scholar 

  53. Medbo A, Melbye H. Lung function testing in the elderly: can we still use FEV1/FVC<70% as a criterion of COPD? Respir Med 2007 Jun; 101(6): 1097–105

    Article  PubMed  Google Scholar 

  54. Garcia-Rio F, Pino JM, Dorgham A, et al. Spirometric reference equations for European females and males aged 65–85 yrs. Eur Respir J 2004 Sep; 24(3): 397–405

    Article  PubMed  CAS  Google Scholar 

  55. Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004 Mar; 23(3): 456–63

    Article  PubMed  CAS  Google Scholar 

  56. Margolis ML, Montoya FJ, Palma Jr WR. Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J 1997 Dec; 90(12): 1187–91

    Article  PubMed  CAS  Google Scholar 

  57. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002 Nov; 20(5): 1117–22

    Article  PubMed  CAS  Google Scholar 

  58. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006 Jul 1; 130(1): 200–6

    Article  PubMed  Google Scholar 

  59. Lau AC-W, Ip MS-M, Lai C-W, et al. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 2008 Jan 1; 133(1): 42–8

    Article  PubMed  Google Scholar 

  60. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003 Aug; 22(2): 268–73

    Article  PubMed  CAS  Google Scholar 

  61. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007 Feb; 131(2): 349–55

    Article  PubMed  Google Scholar 

  62. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005 Oct; 60(10): 842–7

    Article  PubMed  CAS  Google Scholar 

  63. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006 Jun 15; 173(12): 1316–25

    Article  PubMed  Google Scholar 

  64. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007 Aug; 30(2): 232–9

    Article  PubMed  CAS  Google Scholar 

  65. Perez-Padilla R, Torre Bouscoulet L, Vazquez-Garcia JC, et al. Spirometry reference values after inhalation of 200 microg of salbutamol. Arch Bronconeumol 2007 Oct; 43(10): 530–4

    Article  PubMed  Google Scholar 

  66. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007 Jun; 4(2): 113–20

    Article  PubMed  Google Scholar 

  67. Kim SJ, Suk MH, Choi HM, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis 2006 Dec; 10(12): 1393–8

    PubMed  CAS  Google Scholar 

  68. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007 Mar; 62(3): 237–41

    Article  PubMed  Google Scholar 

  69. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994 Nov 16; 272(19): 1497–505

    Article  PubMed  CAS  Google Scholar 

  70. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med 2000 Feb; 161 (2 Pt 1): 381–90

    PubMed  CAS  Google Scholar 

  71. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute Workshop summary. Bethesda, Maryland, August 29–31, 1995. JAMA 1997 Jan 15; 277(3): 246–53

    Article  PubMed  CAS  Google Scholar 

  72. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000 Apr; 117(4): 1146–61

    Article  PubMed  CAS  Google Scholar 

  73. Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336: 598–600

    Article  PubMed  Google Scholar 

  74. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176(6): 532–55

    Article  PubMed  Google Scholar 

  75. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007 Nov; 147(9): 633–8

    PubMed  Google Scholar 

  76. Wilt TJ, Niewoehner D, Kane RL, et al. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res 2007 Jan; 9(1): 21–32

    Article  PubMed  Google Scholar 

  77. Lin K, Watkins B, Johnson T, et al. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008 Apr 1; 148(7): 535–43

    PubMed  Google Scholar 

  78. Kunisaki KM, Rice KL, Niewoehner DE. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: an appraisal of published evidence. Drugs Aging 2007; 24(4): 303–24

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen L. Wood.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatt, N.Y., Wood, K.L. What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease?. Drugs Aging 25, 717–728 (2008). https://doi.org/10.2165/00002512-200825090-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825090-00001

Keywords

Navigation